COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
about
The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients - a population-based study.Prescriptions for chronic high-dose cyclooxygenase-2 inhibitors are often inappropriate and potentially dangerous.Cardiovascular effects of coxibs.Inflammation and shoulder pain--a perspective on rotator cuff disease, adhesive capsulitis, and osteoarthritis: conservative treatment.Challenges facing age-management/longevity medicine.Neurotrophin activation of NFAT-dependent transcription contributes to the regulation of pro-nociceptive genes.
P2860
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@ast
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@en
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@nl
type
label
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@ast
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@en
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@nl
prefLabel
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@ast
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@en
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
@nl
P2093
P356
P1476
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease
@en
P2093
Daniel H Solomon
David J Graham
Jerry Avorn
Wayne A Ray
P356
10.1002/PDS.798
P577
2003-01-01T00:00:00Z